Rubinstein-Taybi Syndrome
|
0.600 |
Biomarker
|
disease |
CTD_human |
|
|
|
Rubinstein-Taybi Syndrome
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Rubinstein-Taybi Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease.
|
15706485 |
2005 |
Rubinstein-Taybi Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Previous studies have identified cytogenetic deletions in the CREBBP gene in eight to 12% of patients and very recently, Roelfsema et al. reported EP300 gene mutations in three of 92 (3.3%) patients with either true RSTS or different syndromes resembling RSTS.
|
16021471 |
2005 |
Rubinstein-Taybi Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The patients with EP300 mutations displayed the typical facial gestalt and malformation pattern compatible with the diagnosis of RSTS.
|
17220215 |
2007 |
Rubinstein-Taybi Syndrome
|
0.600 |
GeneticVariation
|
disease |
LHGDN |
Confirmation of EP300 gene mutations as a rare cause of Rubinstein-Taybi syndrome.
|
17299436 |
2007 |
Rubinstein-Taybi Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Rubinstein-Taybi syndrome (RSTS) is a rare malformation disorder caused by mutations in the closely related CREBBP and EP300 genes, accounting respectively for up to 60 and 3% of cases.
|
17855048 |
2007 |
Rubinstein-Taybi Syndrome
|
0.600 |
GeneticVariation
|
disease |
LHGDN |
The patients with EP300 mutations displayed the typical facial gestalt and malformation pattern compatible with the diagnosis of RSTS.
|
17220215 |
2007 |
Rubinstein-Taybi Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Confirmation of EP300 gene mutations as a rare cause of Rubinstein-Taybi syndrome.
|
17299436 |
2007 |
Rubinstein-Taybi Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
We report a male child with a deletion of exons 3-8 of the EP300 gene who has RSTS.
|
19353645 |
2009 |
Rubinstein-Taybi Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Mutations in CREBBP and EP300 were identified in approximately 50% and 3% of RSTS patients, respectively.
|
19533794 |
2009 |
Rubinstein-Taybi Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Two patients with EP300 mutations and facial dysmorphism different from the classic Rubinstein-Taybi syndrome.
|
20014264 |
2010 |
Rubinstein-Taybi Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
To detect chromosomal rearrangements indicating novel positional candidate RSTS genes, we used a-CGH to study 26 patients fulfilling the diagnostic criteria for RSTS who were negative at fluorescence in situ hybridisation analyses of the CREBBP and EP300 regions, and direct sequencing analyses of the CREBBP gene.
|
20125191 |
2010 |
Rubinstein-Taybi Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The first case is a 3-year-old female with an exonic deletion of the EP300 gene who has classic facial features of RSTS without the thumb and great toe anomalies, consistent with the milder skeletal phenotype that has been described in other RSTS cases with EP300 mutations.
|
20717166 |
2011 |
Rubinstein-Taybi Syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
Among these are classic disorders such as Angelman syndrome and MECP2-related disorder (formerly Rett syndrome), as well as more recently described clinical entities associated with mutations in CASK, CDKL5, CREBBP, and EP300 (Rubinstein-Taybi syndrome), FOXG1, SLC9A6 (Christianson syndrome), and TCF4 (Pitt-Hopkins syndrome).
|
24839169 |
2014 |
Rubinstein-Taybi Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
In addition, there is an apparent high incidence of preeclampsia in women carrying a child with a mutation in CREBBP/EP300 (Rubinstein-Taybi Syndrome).
|
26171964 |
2015 |
Rubinstein-Taybi Syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
Beyond the expansion of the RSTS-EP300-mutated cohort, this study indicates that EP300-related RSTS cases occur more frequently than previously thought (˜8% vs 3-5%); furthermore, the characterization of novel EP300 mutations in RSTS patients will enhance the clinical practice and genotype-phenotype correlations.
|
24476420 |
2015 |
Rubinstein-Taybi Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The genetic basis of Rubinstein-Taybi syndrome (RSTS), a rare, sporadic, clinically heterogeneous disorder characterized by cognitive impairment and a wide spectrum of multiple congenital anomalies, is primarily due to private mutations in CREBBP (approximately 55% of cases) or EP300 (approximately 8% of cases).
|
25388907 |
2015 |
Rubinstein-Taybi Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Our patient expands the phenotypic spectrum in EP300-related RSTS; this case demonstrates the evolving practice of clinical genomics related to increasing availability of genomic sequencing methods.
|
25712426 |
2015 |
Rubinstein-Taybi Syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
It has been shown that mutations in the genes encoding the cyclic-AMP-regulated enhancer binding protein (CREBBP) and the E1A-binding protein p300 (EP300) contributed to the development of RSTS.
|
25599811 |
2015 |
Rubinstein-Taybi Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
All EP300-mutated individuals show a mild RSTS phenotype and peculiar findings including maternal gestosis, skin manifestation, especially nevi or keloids, back malformations, and a behavior predisposing to anxiety.
|
26486927 |
2016 |
Rubinstein-Taybi Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
First case report of inherited Rubinstein-Taybi syndrome associated with a novel EP300 variant.
|
27964710 |
2016 |
Rubinstein-Taybi Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
We demonstrate that EP300 mutations cause a phenotype that typically resembles the classical RSTS phenotype due to CREBBP mutations to a great extent, although most facial signs are less marked with the exception of a low-hanging columella.
|
27648933 |
2016 |
Rubinstein-Taybi Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
RSTS is caused by de novo mutations in epigenetics-associated genes, including the cAMP response element-binding protein (CREBBP), the gene-encoding protein referred to as CBP, and the EP300 gene, which encodes the p300 protein, a CBP homologue.
|
28523540 |
2017 |
Rubinstein-Taybi Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
iPSC-derived neurons of CREBBP- and EP300-mutated Rubinstein-Taybi syndrome patients show morphological alterations and hypoexcitability.
|
29883886 |
2018 |